Inhibiting GS-FDH to modulate NO bioactivity
Patients needing NO donor therapy or inhibition of pathologically proliferating cells or increased NO bioactivity are treated with a therapeutically effective amount of an inhibitor of glutathione-dependent formaldehyde dehydrogenase.
1. A method for treating a patient afflicted with pathologically proliferating cells, said method comprising administering to said patient a therapeutically effective amount of an inhibitor of glutathione-dependent formaldehyde dehydrogenase.
2. The method of claim 1 where the pathologically proliferating cells comprise pathologic bacteria or fungus and the patient is afflicted with a bacterial or fungal infection which is mediated or caused by the pathologic bacteria or fungus and the administering kills the pathologic bacteria or fungus or reduces the rate of proliferation of the pathologic bacteria or fungus by at least 10%.
3. The method of claim 1 where the pathologically proliferating cells are pathologically proliferating mammalian cells and the administering kills the pathologically proliferating mammalian cells or reduces the rate of proliferation of the pathologically proliferating cells by at least 10%.
4. The method of claim 3 wherein the pathologically proliferating mammalian cells are cancer cells.
5. The method of claim 4 wherein the pathologically proliferating mammalian cells are those in Hodgkin's disease, in small cell lung cancer, in cancer of the breast, in testicular cancer or in prostate cancer.
6. The method of claim 3 wherein the pathologically proliferating cells are those causing restenosis.
7. The method of claim 1 wherein the inhibitor is D-glutathione.